Nanjing Leads Biolabs Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Millions HKD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023
Period Ending	Mar '26 Mar 5, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Debt / Equity Ratio	2.86	1.00	-0.07
Net Debt / Equity Ratio	-1.45	-1.02	0.30
Net Debt / EBITDA Ratio	0.54	1.08	1.15
Net Debt / FCF Ratio	-	2.24	1.37
Quick Ratio	0.88	1.35	0.25
Current Ratio	1.07	1.50	0.26
Return on Assets (ROA)	-	-30.59%	-
Return on Capital Employed (ROCE)	-254.70%	-100.80%	27.80%
Buyback Yield / Dilution	-	-3.56%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.